Sign in

Freshpet, Inc. FRPT

Price 69.7 USD
as of 2026-09-05
60/100
Mixed
Quality54
Growth81
Balance-sheet strength84
Valuation38
Momentum49
Income50

Composite 60/100; the shares have moved about 55% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Valuation ranks 38/100 — a moderate mark against it.

Case for

Balance-sheet strength ranks 84/100 — a strong point in its favour. Growth ranks 81/100 — a strong point in its favour. Quality ranks 54/100 — a slight point in its favour.

Case against

Valuation ranks 38/100 — a moderate mark against it. Momentum ranks 49/100 — a slight mark against it.

What the company does Freshpet manufactures and markets natural fresh meals and treats for dogs and cats under brands including Freshpet, Dognation, and Dog Joy. It distributes through refrigerated displays, retail channels, and digital platforms across the U.S., Canada, and Europe.

Key financials Revenue grew 13.1% with EPS up 79.2%. Margins: gross 41.1%, operating 1.5%, net 17.6%. ROE 17.3%, ROA 3.4%, ROCE 9.3%. Debt/Equity 0.39; interest coverage 11.46, current ratio 6.18.

Stock health Sideravia scores: Quality 43.1, Growth 82.8, Strength 85.5, Valuation 45.1, Momentum 26.7. Piotroski F-Score 6/9, Altman Z 4.08. 12-month return -14.37%, RSI(14) 60.50.

Price vs fair value The stock trades at a PREMIUM of 57.40% to our fair-value estimate and a discount of 34.18% to the analyst 12-month target. - Q2 earnings expected to decline (Zacks 2026-07-29) - Mixed analyst commentary on target delivery (MT Newswires 2026-07-28) - Recent outperformance cited by Zacks (Zacks 2026-07-28) - Oppenheimer maintains bullish stance ahead of Q2 (MT Newswires 2026-07-28)

Looking forward Forward P/E of 35.21 reflects high growth expectations. Analysts see potential upside to $81.50, offset by margin pressure and valuation concerns tied to near-term earnings.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.